Follow
Kanishk Luhach
Kanishk Luhach
Amity Institute of Pharmacy, Amity University
Verified email at amity.edu
Title
Cited by
Cited by
Year
In vitro and in vivo models of BBB to evaluate brain targeting drug delivery
B Sharma, K Luhach, GT Kulkarni
Brain targeted drug delivery system, 53-101, 2019
32*2019
Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD
K Luhach, GT Kulkarni, VP Singh, B Sharma
European Journal of Pharmacology 890, 173663, 2021
272021
Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress
K Luhach, GT Kulkarni, VP Singh, B Sharma
Autism Research 14 (11), 2270-2286, 2021
212021
Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder
K Luhach, GT Kulkarni, VP Singh, B Sharma
Journal of Pharmacy and Pharmacology 73 (11), 1460-1469, 2021
142021
Effect of papaverine on developmental hyperserotonemia induced autism spectrum disorder related behavioural phenotypes by altering markers of neuronal function, inflammation …
K Luhach, GT Kulkarni, VP Singh, B Sharma
Clinical and Experimental Pharmacology and Physiology 48 (4), 614-625, 2021
82021
Vinpocetine ameliorates developmental hyperserotonemia induced behavioral and biochemical changes: role of neuronal function, inflammation, and oxidative stress
K Luhach, G Kulkarni, V Singh, B Sharma
Acta Neurobiologiae Experimentalis 82 (1), 35-51, 2022
32022
Vinpocetine, a PDE1 modulator, regulates markers of cerebral health, inflammation, and oxidative stress in a rat model of prenatal alcohol-induced experimental attention …
N Sharma, K Luhach, LK Golani, B Singh, B Sharma
Alcohol 105, 25-34, 2022
12022
Prenatal and Early Life Environmental Stressors: Chemical Moieties Responsible for the Development of Autism Spectrum Disorder
K Luhach, P Sharma, N Sharma, N Dhiman, H Kharkwal, B Sharma
Neurobiology of Autism Spectrum Disorders, 37-74, 2024
2024
Neuroprotection induced by sulphoraphane in central nervous system disorders
P Sharma, K Luhach, N Dhiman, R Awasthi, H Kharkwal, GT Kulkarni, ...
Natural Molecules in Neuroprotection and Neurotoxicity, 1815-1838, 2024
2024
Neuron navigators: A novel frontier with physiological and pathological implications
P Sandeep, P Sharma, K Luhach, N Dhiman, H Kharkwal, B Sharma
Molecular and Cellular Neuroscience, 103905, 2023
2023
PDE3 inhibition by cilostazol attenuated developmental hyperserotonemia induced behavioural and biochemical deficits in a rat model of autism spectrum disorder
K Luhach, B Singh, H Aggarwal, B Sharma
Research in Autism Spectrum Disorders 99, 102052, 2022
2022
# 128 Cerebral ischemic conditioning responses: Exploring the potential mechanisms for post stroke neuroprotective benefits
A Kaushik, H Aggarwal, K Luhach, P Jain
Journal of Pharmaceutical Chemistry 8 (Supplement), 2022
2022
# 129 Targeting central cannabinoid receptors for exploring their potential ischemic preconditioning like
P Jain, A Kaushik, H Aggarwal, K Luhach
Journal of Pharmaceutical Chemistry 8 (Supplement), 2022
2022
To Study the Role of Pharmacological Modulators of Cyclic Nucleotide Phosphodiesterase Enzyme Family in Experimental Autism Spectrum Disorder
K Luhach
Noida, 0
The system can't perform the operation now. Try again later.
Articles 1–14